Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Phlebotomy × Myeloid × Clear all

Phase

Status

Completed 2 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Myeloid 1

Conditions

Thrombosis 1 Polycythemia Vera 1 Polycythemia 1

Interventions

Cyclophosphamide 46 fludarabine phosphate 36 fludarabine 31 Busulfan 27 Azacitidine 27 Whole-Body Irradiation 23 Imatinib Mesylate 23 Antilymphocyte Serum 23 Mycophenolic Acid 22 Tacrolimus 20 Filgrastim 17 Cytarabine 16 Peripheral Blood Stem Cell Transplantation 15 Methotrexate 15 Melphalan 15 Cyclosporine 15 thymoglobulin 14 venetoclax 13 Thiotepa 11 Granulocyte Colony-Stimulating Factor 11 Radiotherapy 10 Decitabine 10 Dasatinib 10 ruxolitinib 9 nilotinib 9 Stem Cell Transplantation 9 Rituximab 9 Cord Blood Stem Cell Transplantation 9 Methylprednisolone 8 Alemtuzumab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01645124 2012-07-20

CYTO-PV

Consorzio Mario Negri Sud

Phase 3 Terminated

Polycythemia, Polycythemia Vera, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡